SCHEMBL7140018

SCHEMBL7140018

COCCOc1cc(NC(=O)OC(C)(C)C)c(NC(=O)CC(=O)c2cccc(-n3ccnc3)c2)cc1C#Cc1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KIT P10721 1/20 0.37
DDR1 Q08345 1/20 0.37
ABL1 P00519 2/20 0.37
VCP P55072 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
LMNA P02545 2/20 0.34
MAPK1 P28482 1/20 0.34
CYP3A4 P08684 2/20 0.33
ABCB1 P08183 1/20 0.33
ROCK2 O75116 1/20 0.33
CYP2D6 P10635 1/20 0.33
PORCN Q9H237 1/20 0.33
KDM4D Q6B0I6 1/20 0.33
ALDH1A1 P00352 1/20 0.33
MAPT P10636 1/20 0.33
HTT P42858 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7142745 0.90 LMNA (0.37) KITDDR1ABL1L3MBTL1LMNA
SCHEMBL7143253 0.89 ABL1 (0.36) KITDDR1ABL1L3MBTL1LMNA
SCHEMBL7143688 0.88 KDM4D (0.34) KITDDR1ABL1L3MBTL1CYP3A4
SCHEMBL5868817 0.85 ABL1 (0.40) KITDDR1ABL1L3MBTL1LMNA
SCHEMBL7147238 0.85 ABL1 (0.39) KITDDR1ABL1L3MBTL1ROCK2
SCHEMBL7141229 0.85 HTT (0.37) VCPL3MBTL1ALDH1A1HTT
SCHEMBL7138367 0.84 HTT (0.39) VCPL3MBTL1MAPK1ALDH1A1MAPT
SCHEMBL7145881 0.83 ABL1 (0.39) ABL1L3MBTL1CYP3A4ABCB1ROCK2
SCHEMBL7146923 0.83 SLC16A3 (0.36) VCPL3MBTL1ALDH1A1HTT
SCHEMBL7139792 0.83 KDM4D (0.36) KITDDR1ABL1L3MBTL1ROCK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1224174-B1 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS HOFFMANN LA ROCHE (CH) 2003-09-17 EP disclosed
US-6407094-B1 4-5-DIDEHYDRO-1,5-BENZODIAZEPIN-2-ONE DERIVATIVES; PSYCHOLOGICAL, NERVOUS SYSTEM, AND BRAIN DISORDERS; COGNITION ACTIVATORS; ALZHEIMER*S DISEASE, SCHIZOPHRENIA HOFFMANN-LA ROCHE INC. 2002-06-18 US disclosed